Oppenheimer & Co. is sole book-running manager.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on APTO:
- Aptose names Fletcher Payne chief business officer
- Aptose Biosciences price target lowered to $18 from $23 at RBC Capital
- Aptose Biosciences reports Q3 EPS ($1.76), consensus ($2.05)
- Oppenheimer biotechnology analyst to hold an analyst/industry conference call
- APTO Earnings this Week: How Will it Perform?
